tenofovir has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K; Bickel, M; Brodt, HR; Geiger, H; Gröne, HJ; Grützmacher, P; Haack, HS; Jung, O | 1 |
| Awdishu, L; Joy, MS | 1 |
1 review(s) available for tenofovir and Bright Disease
| Article | Year |
|---|---|
Role of Pharmacogenomics in Kidney Disease and Injury.
Topics: Acute Kidney Injury; Azathioprine; Calcineurin Inhibitors; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzymes; Glomerulonephritis; Humans; Hydroxychloroquine; Membrane Transport Proteins; Mycophenolic Acid; Pharmacogenetics; Polymorphism, Genetic; Rituximab; Tacrolimus; Tenofovir | 2016 |
1 other study(ies) available for tenofovir and Bright Disease
| Article | Year |
|---|---|
[Changing spectrum of renal disease in HIV infection].
Topics: Adenine; Adult; AIDS-Associated Nephropathy; Amyloidosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; Cohort Studies; Cross-Sectional Studies; Diabetic Nephropathies; Female; Follow-Up Studies; Germany; Glomerulonephritis; Humans; Hypertension, Renal; Immune Complex Diseases; Kidney; Male; Middle Aged; Nephritis; Organophosphonates; Retrospective Studies; Serum Amyloid A Protein; Tenofovir | 2013 |